Naoki Kai

2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same

Medicament for treating cerebral insufficiency diseases containing 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof

1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same

Pharmaceutical composed of 1-(omega-(3,4-dihydro-2-naphthalenyl)alkyl) cyclic amine derivative

1-[ω-(3,4-dihydro-2-naphthalenyl) alkyl] cyclic amine derivatives and processes for preparation thereof and pharmaceutical composition containing the same

2-(4-ETHYL-1-PIPERAZINYL)-4-(4-FLUOROPHENYL)-5,6,7,8,9,10-HEX- AHYDROCYCL OOCTA(B)PYRIDINE OR ITS ACID-ADDITIVE SALT

2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives and pharmaceutical composition containing the same.

Dérivés de 2-(1-pipérazinyl)-4-phénylcycloalkynopyridines, procédés de préparation et compositions pharmaceutiques les contenant

2- (1-piperazinyl) -4-phenylcycloalkanopyridinderivater, process for their preparation and pharmaceutical composition containing them

2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten. 2- (1-piperazinyl) -4-phenylcycloalkanpyridin derivatives, processes for their preparation and pharmaceutical compositions containing them.